Kusukela mhla zingama-24 kuya kumhla zingama-26 kuNhlangulana wezi-2025, i-CPhI China yesi-23 ibanjelwe ngempumelelo e-Shanghai New International Expo Centre! Umongameli we-JYMed uMnu. Ithimba lizibandakanye ngokuqondile nomjikelezo wokuphila ogcwele wezidakamizwa ze-GLP-1 peptide, enikeza imininingwane yochwepheshe ezindaweni eziyisithupha ezibalulekile: i-R&D, i-CMC, ukukhiqiza, ukulawulwa kwekhwalithi, uchungechunge lokuhlinzeka, nokuthuthukiswa kwebhizinisi.
Phakathi nemihlangano namakhasimende, i-JYMed ibonise kokubili ubuqotho nemiphumela eqinile. Ithimba lethu labaphethe lalihileleke ngokujulile, liletha ukusekela kochwepheshe ekupheleni nokuphela kanye nokuhlola amathuba obambiswano ubuso nobuso.Ngokusungula uchungechunge lwezimpendulo eziqondile oluholwa abaphathi abaphezulu, sabhekana nezinselele kusukela ekuvinjweni kwenqubo ukuya ekunikezeni izingozi ngamamodeli okubambisana avumelana nezimo, angenziwa ngezifiso—ukuguqula umhlangano ngamunye ube indawo yokuthinta yamasu eyakhelwe phezu kokwethembana.
Lapho sinyathela khona akusho ukuphela kochungechunge lwe-peptide kuphela kodwa ukuqala kwempilo engcono.Ngokusungula izinto ezintsha zobuchwepheshe njengempumelelo yethu yesigwedlo kanye nekhasimende njengekhampasi yethu, i-JYMed izibophezele ekubeni umholi womhlaba wonke kumasevisi e-peptide CRDMO.
Mayelana ne-JYMed
I-JYMed yinkampani eyenza imithi eqhutshwa yisayensi egxile ekuthuthukiseni, ekukhiqizeni nasekudayiseni imikhiqizo esekelwe ku-peptide. Sinikezela ngezinsizakalo ze-CDMO zokuphela-to-ekupheleni kozakwethu bemithi, izimonyo, kanye nodokotela bezilwane emhlabeni wonke.
Iphothifoliyo yethu yomkhiqizo ihlanganisa anhlobonhlobo ama-API we-peptide, okuhlanganisa i-Semaglutide ne-Tirzepatide, zombili eziqede ngempumelelo ukufakwa kwe-US FDA DMF.
Ingalo yethu yokukhiqiza, i-Hubei JXBio, isebenzisa imigqa yokukhiqiza ye-peptide API esezingeni eliphezulu ehlangabezana namazinga e-cGMP avela kokubili kwe-US FDA kanye ne-NMPA yaseChina. Isiza sihlanganisa imigqa eyi-10 emikhulu nesikali yokuhlola futhi isekelwa i-QMS eqinile kanye nohlaka oluphelele lwe-EHS.
I-JXBio iphumelele ukuhlolwa kwe-GMP yi-FDA yase-US kanye ne-NMPA yase-China futhi yaziwa izinkampani ezihamba phambili zemithi ngokuzibophezela kwayo ekuvikelekeni, kwikhwalithi, nasekuzibophezeleni kwemvelo.
IMIKHIQIZO EYINHLOKO
Asixhume
Ukuze ufunde kabanzi mayelana namakhono ethu noma ukuhlela umhlangano phakathi nombukiso:
•I-Global API & Cosmetic Imibuzo:+86-150-1352-9272
•Ukubhaliswa kwe-API Nezinsizakalo ze-CDMO (US & EU):+86-158-1868-2250
•I-imeyili: jymed@jymedtech.com
•Ikheli:Isitezi sesi-8 & 9, Isakhiwo soku-1, Ipaki Yezimboni Yezimboni ze-Shenzhen Biomedical Innovation, 14 Jinhui Road, IsiFunda esincane sase-Kengzi, Isifunda sase-Pingshan, e-Shenzhen, e-China.
Isikhathi sokuthumela: Jul-05-2025
